Feasibility and Efficacy Trial of a Culturally Adapted Guided Self-Help CBT Manual for OCD

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPakistan Association of Cognitive Therapists

About this trial

This randomised controlled trial (RCT) aims to assess the feasibility, acceptability, and preliminary efficacy of a culturally adapted, guided self-help cognitive behaviour therapy (CBT) manual specifically designed for individuals with OCD in Pakistan.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Clinical diagnosis of OCD (with or without comorbid depression)

Minimum 5 years of formal education

Residing within commuting distance of the participating sites

Disqualifiers

Current substance use or dependence (diagnosed)

Significant cognitive impairment (e.g., dementia or intellectual disability)

OCD with active psychosis

Trial design

Design model

Parallel

Treatments tested in this trial

  • Culturally adapted Guided Self-Help OCD Manual

    Other intervention

    Participants will receive a culturally adapted guided self-help OCD manual based on culturally adapted CBT principles, designed to be used over ten weeks. The manual includes: Psychoeducation, Exposure and Response Prevention (ERP), Thought distraction techniques, Mood tracking and thought diaries, Identifying and modifying cognitive distortions, Problem-solving and communication strategies, and Relaxation and well-being exercises. Participants will receive the self-help manual at the time of initial assessment and intake, and then will be provided with telephone support. Psychology graduates working as guides will provide weekly telephone support. Intervention will be provided flexibly over 12 weeks. The second contact will be made at the time of final assessment on the 12th week.

Treatment groups

108 Participants
are divided into 2 treatment groups
Group A: Culturally adapted guided self-help OCDExperimental treatment 1 intervention
Group B: Treatment as Usual (TAU)No intervention 0 interventions

Trial outcomes

Primary outcomes

1

Obsessive-compulsive symptoms

As assessed through participants' scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)

Time frame
12 weeks
2

Feasibility and acceptability

Feasibility and acceptability will be assessed through trial procedure, recruitment, retention and informal feedback from participants.

Time frame
12 weeks
3

Clients' satisfaction

The client satisfaction scale will be used. At the end of the intervention, researchers will ask participants to describe their experience. They will be asked to name the sessions they found most or least helpful and to provide suggestions for improving the intervention.

Time frame
12 weeks

Secondary outcomes

1

Anxiety & depression

As assessed through participants' scores on the Hospital Anxiety and Depression Scale (HADS)

Time frame
12 weeks
2

Functionality

As assessed through participants' scores on the WHO Disability Assessment Schedule 2 (WHODAS 2)

Time frame
12 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: